CTNM · ISSUER CIK 1855175
Contineum Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Contineum Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $81K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$81KInsider selling
−$81KNet open-market
Sep 8, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 202618:08 | Sep 8, 2026 | CTNM | CEO and President, Director | S · Sell10b5-1 | $16.46 | −2,500 | 17,217 | -13% | −$41K | ||
| Sep 8, 202618:08 | Sep 8, 2026 | CTNM | CEO and President, Director | M · Exercise10b5-1 | $1.01 | +2,500 | 19,717 | +15% | $3K | ||
| Aug 3, 202618:14 | Aug 3, 2026 | CTNM | CEO and President, Director | S · Sell10b5-1 | $16.01 | −2,500 | 17,217 | -13% | −$40K | ||
| Aug 3, 202618:14 | Aug 3, 2026 | CTNM | CEO and President, Director | M · Exercise10b5-1 | $1.01 | +2,500 | 19,717 | +15% | $3K |